Cargando…
Evaluation of Vascular Event Risk while on Long-term Anti-retroviral Suppressive Therapy [EVERLAST]: Protocol for a prospective observational study
BACKGROUND & OBJECTIVE: Cardiovascular disease (CVD) risk among the HIV population is high due to a combination of accelerated atherosclerosis from the pro-inflammatory milieu created by chronic HIV infection and the potentially adverse metabolic side effects from cART (combination antiretrovira...
Autores principales: | Sarfo, Fred Stephen, Nichols, Michelle, Gebregziabher, Mulugeta, Tagge, Raelle, Asibey, Shadrack Osei, Jenkins, Carolyn, Ovbiagele, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460293/ https://www.ncbi.nlm.nih.gov/pubmed/31011634 http://dx.doi.org/10.1016/j.ensci.2019.100189 |
Ejemplares similares
-
Factors associated with incidence of stroke and heart failure among people living with HIV in Ghana: Evaluating Vascular Event Risk while on Long‐Term Antiretroviral Suppressive Therapy (EVERLAST) Study
por: Sarfo, Fred Stephen, et al.
Publicado: (2021) -
Phone-based Intervention under Nurse Guidance after Stroke (PINGS): study protocol for a randomized controlled trial
por: Sarfo, Fred Stephen, et al.
Publicado: (2016) -
Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment (SMAART): study protocol for a randomized controlled trial
por: Sarfo, Fred Stephen, et al.
Publicado: (2018) -
Validation of the 8-item questionnaire for verifying stroke free status with and without pictograms in three West African languages
por: Sarfo, Fred S., et al.
Publicado: (2016) -
Why everlastings don’t last
por: Crous, P.W., et al.
Publicado: (2011)